Loading...

Brilliant Violet 605™ anti-mouse CD366 (Tim-3) Antibody

Pricing & Availability
Clone
RMT3-23 (See other available formats)
Regulatory Status
RUO
Other Names
T cell immunoglobulin and mucin domain containing 3 protein, hepatitis virus cellular receptor 2, CD366
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
RMT3-23_BV605_CD366_Antibody_1_032224
C57BL/6 mouse splenocytes were stained with anti-mouse CD3ε (clone 145-2C11) PerCP/Fire™ 780 and anti-mouse CD366 (Tim-3) (clone RMT3-23) Brilliant Violet 605™ (left) or rat IgG2a, κ Brilliant Violet 605™ isotype control (right).
  • RMT3-23_BV605_CD366_Antibody_1_032224
    C57BL/6 mouse splenocytes were stained with anti-mouse CD3ε (clone 145-2C11) PerCP/Fire™ 780 and anti-mouse CD366 (Tim-3) (clone RMT3-23) Brilliant Violet 605™ (left) or rat IgG2a, κ Brilliant Violet 605™ isotype control (right).
Compare all formats See Brilliant Violet 605™ spectral data
Cat # Size Price Quantity Check Availability Save
119721 50 µg 243€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD366 (Tim-3) is a transmembrane protein also known as T cell immunoglobulin and mucin domain containing protein-3. Tim-3 is expressed at high levels on Th1 lymphocytes and CD11b+ macrophages. Tim-3 has also been shown to exist as a soluble protein. Cells expressing Tim-3 are present at high levels in the CNS of animals at the onset of experimental autoimmune encephalomyelitis (EAE), a disease mediated by lymphocytes secreting Th1-like cytokines. Tim-3 has been proposed to inhibit Th1-mediated immune responses and promote immunological tolerance.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA).
Preparation
The antibody was purified by affinity chromatography and conjugated with Brilliant Violet 605™ under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.5 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Brilliant Violet 605™ excites at 405 nm and emits at 603 nm. The bandpass filter 610/20 nm is recommended for detection, although filter optimization may be required depending on other fluorophores used. Be sure to verify that your cytometer configuration and software setup are appropriate for detecting this channel. Refer to your instrument manual or manufacturer for support. Brilliant Violet 605™ is a trademark of Sirigen Group Ltd.


Learn more about Brilliant Violet™.

This product is subject to proprietary rights of Sirigen Inc. and is made and sold under license from Sirigen Inc. The purchase of this product conveys to the buyer a non-transferable right to use the purchased product for research purposes only. This product may not be resold or incorporated in any manner into another product for resale. Any use for therapeutics or diagnostics is strictly prohibited. This product is covered by U.S. Patent(s), pending patent applications and foreign equivalents.
Excitation Laser
Violet Laser (405 nm)
Application Notes

Additional reported applications (for relevant formats) include: in vitro1 and in vivo2 blocking of Tim-3, and immunohistochemical staining of frozen sections2. The Ultra-LEAF™ purified antibody (Endotoxin <0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. Nos. 119731-119736).

Application References
  1. Nakae S, et al. 2007. Blood 110(7):2565-8. (FC, Block)
  2. Oikawa T, et al. 2006. J. Immunol. 177(7):4281-7. (FC, Block, IHC)
Product Citations
  1. Schenkel JM, et al. 2021. Immunity. 54:2338. PubMed
  2. Backlund C, et al. 2022. Proc Natl Acad Sci U S A. 119:e2204078119. PubMed
  3. Naranjo S, et al. 2022. Genes Dev. 36:936. PubMed
  4. Zhao K, et al. 2023. Front Immunol. 14:1101769. PubMed
  5. Scherer S, et al. 2023. Nat Immunol. 24:501. PubMed
  6. Swan SL, et al. 2023. Front Immunol. 14:1085547. PubMed
  7. Qi Z, et al. 2022. Nat Commun. 13:182. PubMed
  8. Uzhachenko RV, et al. 2021. Cell Reports. 35(1):108944. PubMed
  9. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  10. Wagle MV, et al. 2021. Nat Commun. 12:2782. PubMed
  11. Chen Z et al. 2019. Immunity. 51(5):840-855 . PubMed
  12. Poillet-Perez L, et al. 2020. Nat Cancer. 1:923. PubMed
  13. Mirando AC, et al. 2020. Oncoimmunology. 9:1760685. PubMed
  14. Gabriel SS, et al. 2021. Immunity. 54(8):1698-1714.e5. PubMed
  15. Beltra JC, et al. 2020. Immunity. 52(5):825-841. PubMed
  16. Chen Z, et al. 2021. Cell. 184(5):1262-1280.e22. PubMed
  17. Di Pilato M, et al. 2021. Cell. 184(17):4512-4530.e22. PubMed
  18. Burger ML, et al. 2021. Cell. 184:4996. PubMed
  19. Freed-Pastor WA, et al. 2021. Cancer Cell. 39:1342. PubMed
  20. Gangoso E, et al. 2021. Cell. 184:2454. PubMed
  21. Dammeijer F, et al. 2020. Cancer Cell. 38(5):685-700.e8. PubMed
RRID
AB_2616907 (BioLegend Cat. No. 119721)

Antigen Details

Structure
Transmembrane protein containing immunoglobulin domain and mucin-like domain; predicted molecular weight 31 kD; can exist as a soluble form lacking mucin and transmembrane domains
Distribution

Expressed on activated Th1 lymphocytes and CD11b+ macrophages

Function
May play a role in the development of immune responses and the development of Th1-mediated responses
Ligand/Receptor
Putative ligand on resting CD4+ lymphocytes
Cell Type
Macrophages, Th1
Biology Area
Immunology, Inhibitory Molecules
Molecular Family
CD Molecules, Immune Checkpoint Receptors
Antigen References

1. Sabatos CA, et al. 2003. Nat. Immunol. 4:1102.
2. Sanchez-Fueyo A, et al. 2003. Nat. Immunol. 4:1102.
3. Kuchroo VK, et al. 2003. Nat. Rev. Immunol. 3:454.
4. Mooney L, et al. 2002. Nature 415:536.

Gene ID
171285 View all products for this Gene ID
UniProt
View information about CD366 on UniProt.org

Related FAQs

There are no FAQs for this product.
Go To Top Version: 1    Revision Date: 06/24/2016

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account